Table 1.
Sample characteristics (N = 241).
| N | % | ||
|---|---|---|---|
| Sex | |||
| Females | 164 | 68.0 | |
| Males | 77 | 32.0 | |
| Age | |||
| Years; 95% CI: 26.9–30.5; (median; IQR) | 28.00 | 24.00–40.00 | |
| Location | |||
| Northern Italy | 139 | 57.7 | |
| Central Italy | 53 | 22.0 | |
| Southern Italy | 49 | 20.3 | |
| Profile | |||
| RNs attending an MSN | 126 | 52.3 | |
| RNs with no ongoing university education | 115 | 47.7 | |
| Work settings (n = 61 workers) | |||
| Critical care | 29 | 12.0 | |
| Medical care | 47 | 19.5 | |
| Surgical care | 57 | 23.7 | |
| Primary care | 56 | 23.2 | |
| Outpatient services | 52 | 21.6 | |
| COVID-19 vaccine* | |||
| Yes | 237 | 97.1 | |
| Number of COVID-19 Vaccine Boosters | |||
| No boosters (unvaccinated respondents) | 7 | 2.9 | |
| One booster | 11 | 4.6 | |
| Two boosters | 71 | 29.5 | |
| Three or more boosters | 152 | 63.1 | |
| Decision Regret Scale | |||
| Score; 95% CI: 1.85–2.17; (median; IQR) | 2.0 | 1.6–3.0 | |
| Adult Vaccine Hesitancy Scale | |||
| Score of Trust in Vaccine Efficacy and Benefits; 95% CI: 1.59–1.83; (median; IQR) | 1.75 | 1.0–2.0 | |
| Score of Concerns about Vaccine Safety; 95% CI: 2.70–2.92; (median; IQR) | 2.67 | 2.0–3.0 | |
| Score of Trust in Health Authorities and Compliance; 95% CI: 1.97–2.21; (median; IQR) | 2.0 | 1.3–2.3 | |